Tag School of Pharmacy
William E. Evans, chief executive officer of St. Jude’s Children’s Research Hospital and an expert on the treatment of pediatric cancer, and a research leader in the effect of genetics to the response to drugs, will deliver the 2009 Rennebohm Lecture on Thursday, Sept. 10.
By shifting a normal protective mechanism into overdrive, a University of Wisconsin–Madison scientist has completely shielded mice from a toxic chemical that would otherwise cause Parkinson's disease.
By guiding an enzyme down a new evolutionary pathway, a team of University of Wisconsin–Madison researchers has created a new form of an enzyme capable of producing a range of potential new therapeutic agents with anticancer and antibiotic properties.
A University of Wisconsin–Madison pharmacy professor aims to improve the delivery of cancer-fighting drugs by targeting them more selectively to tumors and boosting their solubility in water.